Health In Tech, Inc.

EDGAR

Market value is not computed: no listed ticker is recorded for this company.

Annual consolidated revenue for 2025: about USD 33.33M, using the latest reported figures. The previous period, 2024, was about USD 19.49M.

Watchlist

Holdings and insider activity

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, over the last 12 months.

Window: transactions dated on or after 2025-11-18.

Open-market purchases (code P)
0 transactions, — shares
Open-market sales (code S)
6 transactions, 46,397 shares
Sum of shares × price per share: 40,681.85

Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.

  • 2026-11-10 Qian LinLin A 650,000 0
  • 2026-11-10 Qian LinLin A 800,000 0
  • 2026-11-10 Qian LinLin A 600,000 0
  • 2026-11-10 Qian LinLin A 600,000 0
  • 2026-11-10 Qian LinLin A 200,000 0

5% holders (Schedule 13D and 13G)

  • LYTTON LAURENCE W 6.2% SCHEDULE 13G 03/27/2026

See all insider transactions

Latest quarter

Revenue

6.59 million USD

2026 Q3 · USD

Exact inputs and evidence

Net margin

-107.28%

2026 Q3 · %

Exact inputs and evidence

Operating cash flow

-1.05 million USD

2026 Q3 · USD

Exact inputs and evidence
  • Operating Cash Flow: -7277043 USD Source
  • Operating Cash Flow: -6231567 USD Source
Cash and cash equivalents
6.51 million USD Source
Exact value

6514813 USD

Long-term debt including current maturities
Not available
Shares outstanding
Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

30.9 million USD

2025-10-01 – 2026-09-30

Exact inputs and evidence
  • Revenue: 33327511 USD · 2025-01-01 – 2025-12-31 Source
  • Revenue: 25818926 USD · 2025-01-01 – 2025-09-30 Source
  • Revenue: 8771646 USD · 2026-01-01 – 2026-03-31 Source
  • Revenue: 8056620 USD · 2026-04-01 – 2026-06-30 Source
  • Revenue: 6587052 USD · 2026-07-01 – 2026-09-30 Source

Net income

-11.5 million USD

2025-10-01 – 2026-09-30

Exact inputs and evidence
  • Net income: 1278842 USD · 2025-01-01 – 2025-12-31 Source
  • Net income: 1581399 USD · 2025-01-01 – 2025-09-30 Source
  • Net income: -1588281 USD · 2026-01-01 – 2026-03-31 Source
  • Net income: -2511024 USD · 2026-04-01 – 2026-06-30 Source
  • Net income: -7066413 USD · 2026-07-01 – 2026-09-30 Source

Operating cash flow

-6.83 million USD

2025-10-01 – 2026-09-30

Exact inputs and evidence
  • Operating cash flow: 3133813 USD · 2025-01-01 – 2025-12-31 Source
  • Operating cash flow: 2682602 USD · 2025-01-01 – 2025-09-30 Source
  • Operating cash flow: -3319247 USD · 2026-01-01 – 2026-03-31 Source
  • Operating cash flow: -6231567 USD · 2026-01-01 – 2026-06-30 Source
  • Operating cash flow: -3319247 USD · 2026-01-01 – 2026-03-31 Source
  • Operating cash flow: -7277043 USD · 2026-01-01 – 2026-09-30 Source
  • Operating cash flow: -6231567 USD · 2026-01-01 – 2026-06-30 Source

Company performance

Up to ten complete financial years · consolidated figures

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-11-13.

Financial data available through: 2025-12-31.

Coverage by financial measure
  • Revenue: 3 of 11 periods available· newest 2025-12-31
  • operating income: No compatible figures in this window
  • Net income: 2 of 11 periods available· newest 2025-12-31
  • Operating cash flow: 3 of 11 periods available· newest 2025-12-31
  • capital expenditure: No compatible figures in this window
  • Total assets: 3 of 11 periods available· newest 2025-12-31
  • Total liabilities: 3 of 11 periods available· newest 2025-12-31
  • Current assets: 3 of 11 periods available· newest 2025-12-31
  • Current liabilities: 3 of 11 periods available· newest 2025-12-31
  • Cash and cash equivalents: 3 of 11 periods available· newest 2025-12-31
  • long term debt: No compatible figures in this window
  • shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

  • Revenue

    +71%

    Prior period

    USD 19.49 million

    –

    Current period

    USD 33.33 million

    –

    Exact inputs and evidence

    33327511 − 19490906 = 13836605 USD

    19490906 USD · 2024-01-01 – 2024-12-31

    Inspect prior input Prior source

    33327511 USD · 2025-01-01 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Net income

    +90.7%

    Prior period

    USD 670,477

    –

    Current period

    USD 1.28 million

    –

    Exact inputs and evidence

    1278842 − 670477 = 608365 USD

    670477 USD · 2024-01-01 – 2024-12-31

    Inspect prior input Prior source

    1278842 USD · 2025-01-01 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Operating cash flow

    +44%

    Prior period

    USD 2.18 million

    –

    Current period

    USD 3.13 million

    –

    Exact inputs and evidence

    3133813 − 2176209 = 957604 USD

    2176209 USD · 2024-01-01 – 2024-12-31

    Inspect prior input Prior source

    3133813 USD · 2025-01-01 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2025 2025-01-01 – 2025-12-31

  • Revenue USD 33.33 million 100% of revenue
  • Operating costs Derived Unavailable An input is unavailable.
  • Operating income Unavailable An input is unavailable.
  • Tax, interest and other Derived Unavailable An input is unavailable.
  • Net income USD 1.28 million 3.8% of revenue

Cash

  • Operating cash flow USD 3.13 million 9.4% of revenue
  • Capital expenditure Unavailable An input is unavailable.
  • Free cash flow Derived Unavailable An input is unavailable.

Share of revenue by period

  • Net income
  • Tax, interest and other
  • Operating costs
  • 2023 Not shown: operating income or net income is not reported.
  • 2024 Not shown: operating income or net income is not reported.
  • 2025 Not shown: operating income or net income is not reported.
Values and sources
Revenue breakdown by annual reporting period
PeriodRevenueOperating costsOperating incomeTax, interest and otherNet incomeFree cash flowSource
2023 2023-01-01 – 2023-12-3119151502 UnavailableUnavailableUnavailableUnavailableUnavailable
Source
2024 2024-01-01 – 2024-12-3119490906 UnavailableUnavailableUnavailable670477 Unavailable
Source
2025 2025-01-01 – 2025-12-3133327511 UnavailableUnavailableUnavailable1278842 Unavailable
Source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 33.3M 2025
Revenue historyRevenue reported for each complete financial period. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.36.0M27.0M18.0M9.0M0.0202320242025
Values and sources
Revenue values and source evidence
PeriodSeriesValue(USD)Source evidence
2023Revenue19151502
2024Revenue19490906
2025Revenue33327511

Revenue growth

Change in revenue from the same financial period one year earlier.

71% 2025
Revenue growth historyChange in revenue from the same financial period one year earlier. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.77%58%38%19%0%202320242025
Values and sources
Revenue growth values and source evidence
PeriodSeriesValueSource evidence
2023Year over yearNo prior comparable period
2024Year over year1.8%
2025Year over year71%

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Net margin 3.8% 2025
Profit margins historyOperating income, net income and free cash flow as a share of revenue. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.4.1%3.1%2.1%1.0%0.0%2023-12-312024-12-312025-12-31
  • Operating margin
  • Net margin
  • Free cash flow margin
Values and sources
Profit margins values and source evidence
PeriodSeriesValueSource evidence
2023-12-31Operating marginNot reported
2024-12-31Operating marginNot reported
2025-12-31Operating marginNot reported
2023-12-31Net marginNot reported
2024Net margin3.4%
2025Net margin3.8%
2023Free cash flow marginNot reported
2024Free cash flow marginNot reported
2025Free cash flow marginNot reported

Operating cash flow

Cash generated by the company’s normal business operations.

USD 3.1M 2025
Operating cash flow historyCash generated by the company’s normal business operations. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.3.4M2.5M1.7M846.1K0.0202320242025
Values and sources
Operating cash flow values and source evidence
PeriodSeriesValue(USD)Source evidence
2023Operating cash flow1528878
2024Operating cash flow2176209
2025Operating cash flow3133813

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.
Values and sources
Free cash flow values and source evidence
PeriodSeriesValue(USD)Source evidence
2023Free cash flowUnavailable
2024Free cash flowUnavailable
2025Free cash flowUnavailable

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

25.9% 2025
Liabilities to assets historyTotal liabilities as a share of total assets. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.51%38%25%13%0%202320242025
Values and sources
Liabilities to assets values and source evidence
PeriodSeriesValueSource evidence
2023Liabilities / assets47%
2024Liabilities / assets16.5%
2025Liabilities / assets25.9%

Current assets to current liabilities

Current assets divided by current liabilities.

3.13× 2025
Current assets to current liabilities historyCurrent assets divided by current liabilities. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.5.47×4.10×2.73×1.37×0.00×202320242025
Values and sources
Current assets to current liabilities values and source evidence
PeriodSeriesValueSource evidence
2023Current assets / current liabilities1.43×
2024Current assets / current liabilities5.06×
2025Current assets / current liabilities3.13×

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
PeriodNet incomeOperating cash flowCapital expenditureFree cash flow
2023 2023-01-01 – 2023-12-31
Unavailable Not reported for this period.
USD 1.53 million
Exact value

Exact value: 1528878 USD

2023-01-01 – 2023-12-31: 1528878 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

2024 2024-01-01 – 2024-12-31
USD 670,477
Exact value

Exact value: 670477 USD

2024-01-01 – 2024-12-31: 670477 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 2.18 million
Exact value

Exact value: 2176209 USD

2024-01-01 – 2024-12-31: 2176209 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

2025 2025-01-01 – 2025-12-31
USD 1.28 million
Exact value

Exact value: 1278842 USD

2025-01-01 – 2025-12-31: 1278842 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 3.13 million
Exact value

Exact value: 3133813 USD

2025-01-01 – 2025-12-31: 3133813 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

19 filings · 691 latest values · 691 originally reported values

Dataset published . Source filing dates and reporting periods are shown separately.

Identifiers: 0002019505, 2019505, HIT, edgar:2019505

Also known as Health In Tech, Inc.